EML4-ALK-harbouring NSCLC cells were stimulated with heregulin β-1 (HRG), an ERBB3 ligand, and the phosphorylation of ERBB receptors and signalling pathways were analysed. Here, HRG is linked to non-small cell lung carcinoma.